| NCT ID | NCT04976712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Azienda Sanitaria dell'Alto Adige |
| Condition | Out-Of-Hospital Cardiac Arrest |
| Study Type | OBSERVATIONAL |
| Enrollment | 256 participants |
| Start Date | 2021-07-01 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 256 participants in total. It began in 2021-07-01 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective observational study aiming to monitor core temperature via an esophageal probe in out of hospital cardiac arrest during transport and until arrival in hospital. Insertion of an esophageal temperature probe will be done on scene during ongoing resuscitation manoeuvres based on European Resuscitation Council Guidelines 2015 (or newer). Environmental temperature influence and hypothermia prevention interventions will be monitored.
Eligibility Criteria
Inclusion Criteria: * Out of hospital cardiac arrest * Patients transferred to hospital * \> 18 years Exclusion Criteria: * Obvious signs of death * Obvious lethal injury/injuries incompatible with life * Confirmation of death on scene * \< 18 years
Contact & Investigator
Rosmarie Oberhammer, MD
STUDY DIRECTOR
Azienda Sanitaria dell'Alto Adige
Frequently Asked Questions
Who can join the NCT04976712 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Out-Of-Hospital Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04976712 currently recruiting?
Yes, NCT04976712 is actively recruiting participants. Contact the research team at rosmarie.oberhammer@sabes.it for enrollment information.
Where is the NCT04976712 trial being conducted?
This trial is being conducted at Bruneck, Italy.
Who is sponsoring the NCT04976712 clinical trial?
NCT04976712 is sponsored by Azienda Sanitaria dell'Alto Adige. The principal investigator is Rosmarie Oberhammer, MD at Azienda Sanitaria dell'Alto Adige. The trial plans to enroll 256 participants.